In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...